Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

  • Go to Emergencies.
  • Contact us:

    Campus Charité MitteInvalidenstraße 80 / Virchowweg 23
    10117 Berlin

  • Accessibility:
    Contrast Settings Change contrast
    Font size
    Font size bigger: STRG+ Font size smaller: STRG-

    You can enlarge or reduce the browser window. Please use CTRL and + to zoom in or CTRL and - to zoom out. Press CTRL and 0 to reset your browser window to normal size.

Open Menu
© Charité | Wiebke Peitz

News from the centers

08.11.2016

DKTK Berlin: Boost for cancer therapies with tumors grown in petri-dish

Back to Overview

You are here:

2,6 Millionen Euros fot the Charité Berlin

Foto: Joseph Regan

Cancer can be caused by a variety of genetic mutations. One challenge medicine faces is finding tailor-made treatment for each patient based on their individual genetic differences. Scientists at the German Cancer Consortium (DKTK) at the Charité Comprehensive Cancer Center in Berlin have now received 2.6 million Euros so, together with regional biotechnology companies, they can make test systems available for personalized medication screening. The German Cancer Consortium (DKTK) builds a strong, long-term, institutional structure between the German Cancer Research Center (DKFZ) and universities and university hospitals all over Germany specially designated to clinical oriented cancer research.

Please read the news here.

  
  
  
  
  
  

  
  
  
  
  
  
  
  
  
  
  
 

Contact

https://dktk.dkfz.de/en/about-us/news/dktk-berlin-boost-cancer-therapies-tumors-grown-petri-dish



Back to Overview